With Nu Skin’s (NUS) arriving benefit recover on Thursday, Apr 26, 2012, an financier who is prolonged a company’s batch can use a stable lonesome call in sequence to strengthen a benefit for a stock, as an financier in a association over a final year has doubled their income as shown below:
Additionally, an financier can also name a stable lonesome call in sequence to take advantage of receiving a company’s approaching division remuneration in May/June. Since Nu Skin’s ex-dividend date was nearby a finish of May in 2011, a hunt will be achieved for a stable call for a month of June. A stable lonesome call might be entered by offered a call choice opposite an existent or purchased batch and regulating some of a deduction from offered a call choice to squeeze a protecting put option.
Using PowerOptions tools, we found a stable lonesome call for Nu Skin with a intensity lapse of 2.7% (18.6% annualized) and a limit intensity detriment of 12.9%, even if a cost of a batch goes to zero, a limit intensity detriment is 12.9%. The position with other intensity positions are shown below:
Including an approaching division remuneration of $0.20 in May/June for a stable lonesome call position formula in a 2.8% intensity lapse with limit detriment of 12.6%. As a bonus, if a cost of a batch is larger than or equal to a $60 call choice strike cost during expiration, a position will lapse 4.8%. The specific call choice to sell is a 2012 Jun 60 during $2.20 and a put choice to squeeze is a 2012 Jun 50 during $0.65. A profit/loss graph for one agreement of a stable lonesome call is shown below:
If a cost of a batch increases to around $65, a stable lonesome call position can many expected be rolled in sequence to comprehend additional intensity return.
Nu Skin Enterprises apparently done a intelligent pierce when it participated in a Backstage Bag Luxury Lounge’ during a 2012 Academy Awards, garnering useful broadside for a ageLOC anti-aging products given to photogenic and newsworthy celebrities, stylists and media representatives, as many Hollywood celebrities have dual vital investments to take caring of: their face and their childish appearance. Three weeks after Nu Skin was in a news again, this time in a feature essay in Women’s Wear Daily (pdf) concentrating on a company’s business success rather than touting a efficacy of a merchandise.
There is no doubt about that success. Nu Skin’s February 2012 financier presentation(pdf) non-stop with a 23% year-on-year tellurian income enlargement achieved in a fourth entertain of 2011, including a record-breaking $100 million product launch of R² dietary supplements and Galvanic Spa anti-cellulite treatments. FY 2011 sum income was $1.74 billion, and other formula in a record year enclosed a 27% boost in benefit per share and a lift of 120 basement points in handling margin. The significance of a company’s Asian markets is underlined in a sum for income by region: North Asia 43% (27% from Japan alone), Greater China 20%, South Asia/Pacific 14%, Americas 14%, Europe 9%. Q4 2011 quarterly fact sheet (pdf) Emerging markets grew by 27% in 2011, and serve double-digit enlargement is foresee for 2012. Net income for 2011 was $153 million ($2.38 per diluted share). Cash from operations has grown any year given 2007 in line with earnings, reaching $224 million in 2011. Company superintendence puts 2012 income in a operation $1.81-1.84 million, and EPS between $2.84 and $2.94. (Q4 2011 benefit press release)
Revenue is divided between Nu Skin anti-aging skin caring treatments, generating 57% of a 2011 total, and Pharmanex anti-aging and weight supervision dietary supplements, contributing a remaining 43%. The association prides itself on a systematic basement for a merchandise, bolstered by a new merger of a technical collaborator, genomics association LifeGen Technologies. Nu Skin’s Chief Scientific Officer, Dr Joseph Chang, was a co-founder of Pharmanex, a association Nu Skin acquired in 1998 as a basement for a dietary addition range. He is a author of a New York Times best seller The Aging Myth’, that is proof to be an glorious source of certain broadside for ageLOC. The association spent $13.6 million on RD in 2011.
The ageLOC product line has already constructed $1 billion in income given a 2008 introduction, and a company’s destiny enlargement skeleton are formed on new product expansion within this operation of sell and on assertive enlargement in rising markets. Except in mainland China, Nu Skin’s tellurian sales are conducted by commission-based face-to-face hit by distributors, a business indication that appears to be operative quite well. The sum series of active distributors has grown to 855,000 during a finish of 2011, while ‘Executive’ distributors (earning during slightest $4,968 in annual commission) rose by 17% to around 42,000.
Revenue enlargement is clearly related to enlargement in distributor numbers. Distributors are no doubt captivated and encouraged by a company’s inexhaustible elect rates (which it says volume to 42% of sales), a ability to money in on sell mark-ups, and a event to rise an eccentric business formed on auxiliary distributors they have themselves recruited. Nu Skin provides distributors with training and support. However, many of a people personal as ‘distributors’ do not acquire commission, and are in fact business who squeeze products directly from Nu Skin during ignored prices by an involuntary subscription program. Sales in mainland China are conducted by a mix of genuine distributors, an employed sales force and approach resellers.
Since 88% of Nu Skin’s income comes from markets outward a United States, it is acutely unprotected to a effects of unfamiliar banking fluctuations, quite in a Japanese yen, and to a impact of tellurian economic, business and domestic conditions. It also faces a substantial risk in a faith on agreements with 4 vital suppliers, whom it does not name, for a bulk of a products it sells. The association usually engages in a possess prolongation to a singular extent, during dual prolongation comforts in China.
A approach offered indication introduces another set of problems, creation it required for Nu Skin to denote to supervision agencies that it is not a upholder of a ‘pyramid’ scheme. The laws covering approach offered activities are quite limiting in Japan, South Korea and China, whose governments also levy other regulatory hurdles that impact on Nu Skin’s business. The association is operative tough to strengthen a 27% of a sum income generated in Japan, where it has perceived a vast series of complaints from consumer insurance groups. Nu Skin’s competitors in a approach offered of personal caring products embody Herbalife (HLF), privately-held companies Amway, Mary Kay and Forever Living, and Avon (AVP).(Form 10-K 2011)
Nu Skin’s boss and CEO, Truman Hunt, reliable a approximately 42% of income paid as commissions when he remarked, during a Q4 2011 benefit discussion call, that a record $750 million was paid to distributors in 2011. He entirely expects 2012 to be another record year, and that a best is nonetheless to come in 2013 with dual vital new product launches. (Q4 2011 benefit call webcast)
There is no doubt that many women (and men), not only Hollywood celebrities, are prepared to compensate tip dollar for a possibilities of childish vitality and metamorphosis that come with Nu Skin’s products. Its distributor indication has served it good in those countries where approach offered is an supposed approach of retailing. However, in annoy of a new healthy enlargement and a destiny prospects, Nu Skin does face a series of problems combined by a coherence on abroad markets, quite in Asia. As is a box with a products’ promises, a best recommendation might be ‘believe with caution’ and use protecting investment strategies, like a stable lonesome call, only in case.
Disclosure: I have no positions in any bonds mentioned, and no skeleton to trigger any positions within a subsequent 72 hours.